Our Pick Of The Best Australian Growth Stocks In October 2026

AI chip demand has pushed Samsung and TSMC to record results, reminding investors how quickly growth stories can reshape whole sectors when the right trend hits. Australian high growth potential stocks aim to tap into similar momentum, backed by expectations for rising sales and earnings and relatively strong balance sheets. This article walks through three of the most compelling candidates from that group so you can judge which stories resonate.

The three stocks highlighted next are just a small sample. The full screen surfaces 27 more high growth potential companies with similarly compelling stories that are not covered here.

If you want to quickly identify and analyze the wider opportunity set, head straight to the Best high growth potential screener.

Resolute Mining (ASX:RSG)

Resolute Mining is a Perth based gold producer focused on Africa, where the Doropo Gold Project in Côte d’Ivoire anchors its high growth potential story alongside existing operations at Syama in Mali with about $696 million in revenue and Mako in Senegal with roughly $307 million. The miner has a market value near A$2.4b.

Resolute Mining sits in this high growth screener because current production and a pipeline of West African projects give it a clear path to scale, with Doropo in particular positioned as the next leg of the story rather than a distant hope.

"The Doropo, ABC, and La Debo projects in Côte d'Ivoire, alongside the Syama Sulphide Conversion Project and life extension at Mako (through Bantaco and Tomboronkoto), are expected to significantly increase production volumes to over 500,000 ounces by 2028, driving sustained top-line growth and greater economies of scale that can enhance profitability."

What matters now is how one pressure on future margins and cash generation ultimately plays out against those growth ambitions.

That trade off is exactly what the full narrative for Resolute Mining unpacks, including where capital intensity, country risk and project timing could be masking the Resolute Mining upside story.

Neuren Pharmaceuticals (ASX:NEU)

Neuren Pharmaceuticals develops treatments for neurological disorders, with high growth potential tied closely to DAYBUE for Rett syndrome and a follow on pipeline led by NNZ 2591. The group generated about A$69 million from commercial products and carries a market value near A$2.6b.

Neuren Pharmaceuticals taps into the high growth theme through a commercial rare disease drug already generating meaningful royalty income, plus a late stage pipeline that offers multiple avenues for earnings to expand if milestones land.

"Planned expansion into international markets, such as Canada, Europe, and Japan, offers significant long-term growth prospects and additional revenue streams due to higher royalty rates outside the U.S."

What matters most from here is how one evolving pressure on profitability interacts with those royalty rich markets investors are counting on.

That trade off is where things get interesting, and the full narrative for Neuren Pharmaceuticals shows how accelerating royalties could interact with R&D spend, partnerships and future deal terms.

Lynas Rare Earths (ASX:LYC)

Lynas Rare Earths runs the Mt Weld mine in Western Australia and processing plants in Kalgoorlie and Malaysia, producing rare-earth oxides used in electric vehicles and renewables. All A$978 million in revenue comes from Rare Earth Operations, and the business is valued around A$12.5b.

Lynas Rare Earths is closely aligned with the high growth potential theme because it already links rare-earth mining with processing, giving investors exposure to a full supply chain that is tightly tied to EVs, renewables and Western critical minerals policy support.

"Investors appear to expect sustained above-trend pricing and demand, largely based on the belief that Western governments' ongoing support for supply chain diversification and critical mineral security will continue to provide Lynas with long-term government-backed offtake agreements and pricing floors, driving higher future revenue and valuation multiples."

What really matters is how shifting policy and pricing pressure ultimately shape the rare-earth margins that this growth story leans on.

Those policy swings and pricing pressures are exactly what the full narrative for Lynas Rare Earths unpacks, highlighting where rare earth demand trends could accelerate or mask risk.

Seeking Fresh Alternatives Before They Fly

Markets move fast. Breakout stories gain momentum while slower ideas get left behind. Scan fresh stock ideas that may be under the radar for now and act now.

• Spot potential income workhorses before yields get compressed by latecomers with a curated set of 5 dividend fortresses designed to keep paying while it matters.
• Track early movers in electrification and infrastructure, where smarter grids and power hardware quietly build momentum through a focused group of 43 power grid technology and infrastructure stocks.
• Position ahead of the next materials squeeze by reviewing a tightly filtered pool of 33 best rare earth metal stocks that could benefit if demand pressure returns.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com